NYSE: NX
Quanex Building Products Corp Stock

$16.44-0.19 (-1.14%)
Updated Apr 30, 2025
NX Price
$16.44
Fair Value Price
N/A
Market Cap
$776.47M
52 Week Low
$15.30
52 Week High
$35.92
P/E
41.1x
P/B
0.8x
P/S
0.69x
PEG
0.09x
Dividend Yield
1.95%
Revenue
$1.44B
Earnings
$11.93M
Gross Margin
24.1%
Operating Margin
3.33%
Profit Margin
0.8%
Debt to Equity
1.28
Operating Cash Flow
$72M
Beta
1.13
Next Earnings
Jun 4, 2025
Ex-Dividend
N/A
Next Dividend
N/A

NX Overview

Quanex Building Products Corporation offers components to the fenestration industry (e.g., flexible insulating glass spacers, extruded vinyl profiles, and window and door screens), as well components for OEMs in the kitchen and bathroom cabinet industry. The company also offers non-fenestration components and products (e.g., solar panel sealants, trim moldings, vinyl decking, fencing, water retention barriers, and conservatory roof components). Quanex was founded in 1927 and is headquartered in Houston, TX.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine NX's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Building Product & Equipment

Industry Rating
D
NX
Ranked
#8 of 29

Top Ranked Stocks in Industry

View Top Building Product & Equipment Stocks

Be the first to know about important NX news, forecast changes, insider trades & much more!

NX News

Overview

Due Diligence Score

Industry Average (39)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NX ($16.44) is trading below its intrinsic value of $64.77, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NX is poor value based on its earnings relative to its share price (41.1x), compared to the US market average (29.18x)
P/E vs Market Valuation
NX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NX due diligence checks available for Premium users.

Valuation

NX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
41.1x
Industry
23.67x
Market
29.18x
NX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

NX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.8x
Industry
4.97x
NX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NX price to earnings growth (PEG)

For valuing profitable companies with growth potential

NX is good value based... subscribe to Premium to read more.
PEG Value Valuation

NX's financial health

Profit margin

Revenue
$400.0M
Net Income
-$14.9M
Profit Margin
-3.7%
NX's Earnings (EBIT) of $47.97M... subscribe to Premium to read more.
Interest Coverage Financials
NX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.2B
Liabilities
$1.2B
Debt to equity
1.28
NX's short-term assets ($547.62M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NX's long-term liabilities ($1.02B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$12.5M
Investing
-$11.5M
Financing
-$22.0M
NX's operating cash flow ($72.45M)... subscribe to Premium to read more.
Debt Coverage Financials

NX vs Building Product & Equipment Stocks

TickerZen RatingMarket Cap1d %P/EP/B
NXC$776.47M-1.14%41.10x0.80x
APOGC$849.70M-1.76%10.15x1.74x
SWIMC$632.72M-1.89%-36.43x1.63x
JBIC$965.34M-2.55%14.04x1.86x
ARLOC$1.01B-1.01%-31.71x9.98x

Quanex Building Products Stock FAQ

What is Quanex Building Products's quote symbol?

(NYSE: NX) Quanex Building Products trades on the NYSE under the ticker symbol NX. Quanex Building Products stock quotes can also be displayed as NYSE: NX.

If you're new to stock investing, here's how to buy Quanex Building Products stock.

What is the 52 week high and low for Quanex Building Products (NYSE: NX)?

(NYSE: NX) Quanex Building Products's 52-week high was $35.92, and its 52-week low was $15.30. It is currently -54.23% from its 52-week high and 7.45% from its 52-week low.

How much is Quanex Building Products stock worth today?

(NYSE: NX) Quanex Building Products currently has 47,230,263 outstanding shares. With Quanex Building Products stock trading at $16.44 per share, the total value of Quanex Building Products stock (market capitalization) is $776.47M.

Quanex Building Products stock was originally listed at a price of $12.50 in Dec 31, 1997. If you had invested in Quanex Building Products stock at $12.50, your return over the last 27 years would have been 31.54%, for an annualized return of 1.02% (not including any dividends or dividend reinvestments).

How much is Quanex Building Products's stock price per share?

(NYSE: NX) Quanex Building Products stock price per share is $16.44 today (as of Apr 30, 2025).

What is Quanex Building Products's Market Cap?

(NYSE: NX) Quanex Building Products's market cap is $776.47M, as of May 2, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Quanex Building Products's market cap is calculated by multiplying NX's current stock price of $16.44 by NX's total outstanding shares of 47,230,263.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.